What insurance policy changes affect Oklahoma providers?

This page tracks changes from major payers (including Medicaid managed care, commercial insurers, and Medicare Advantage plans) that explicitly apply to Oklahoma. Changes include prior authorization updates, billing code additions or deletions, and reimbursement rate revisions.

How often are Oklahoma policy changes updated?

Our scrapers run daily and publish new findings within 24 hours of detection. Each change includes an effective date where stated so you can prioritize what requires immediate action.

How do I get alerted to new Oklahoma insurance policy changes?

Create a free alert on PolicyChanges.app and filter by state to Oklahoma. You will get an email when new matching changes are detected: daily or weekly, your choice, on every plan.

PAYER POLICY CHANGES

Oklahoma Insurance & Medicaid Policy Updates

Oklahoma providers face a continuous stream of payer policy changes: coverage edits, prior authorization expansions, billing code revisions, and Medicaid reimbursement updates that affect day-to-day practice operations. This page surfaces every tracked policy change that explicitly names Oklahoma, so your billing and compliance teams can act before the effective date, not after a claim denial.

BCBS Oklahoma · Effective Dec 1, 2026High impact
New Claims Editing Rules To Be Implemented in December 2026
Effective December 1, 2026, Blue Cross Blue Shield of Oklahoma will implement new claims editing rules in their Lyric software that enforce specific drug usage limits and require proper wastage modifier application for six HCPCS codes. Claims that fail these edits will receive rejection reason codes beginning with 'G'. Billing teams must update their claim submission processes to ensure compliance with new quantity limits for injectable drugs and proper documentation of drug wastage.
BCBS Oklahoma · Effective Dec 21, 2026High impact
Prior Authorization Changes for Some Government Program Members
Blue Cross and Blue Shield of Oklahoma is removing prior authorization requirements for specific service categories (proprietary laboratory analyses, drugs/biologics, molecular pathology/genetics, infectious disease molecular testing, radiology, advanced imaging, orthopedic surgery, foot and ankle surgery, plastic/reconstructive surgery, vascular surgery, organ transplant, general surgery, ophthalmology, and miscellaneous specialty procedures) for Medicare Advantage members effective December 21, 2026. Additionally, the plan will begin phasing out Recommended Clinical Review options starting January 1, 2027, with complete removal expected by end of 2027 for most commercial members.
BCBS Oklahoma · Effective Jan 1, 2027High impact
Blue Cross Medicare Advantage (HMO)℠ Members Transitioning to HealthSpring℠ Plan for 2027
Blue Cross Medicare Advantage (HMO) members in Oklahoma are transitioning to HealthSpring plans effective January 1, 2027. Billing teams must update patient records with new HealthSpring ID cards and numbers, verify network participation with HealthSpring, and transition all claims processing and utilization management to HealthSpring procedures starting 2027. Members should continue using BCBSOK ID cards through December 31, 2026.
UnitedHealthcare · Effective Jan 1, 2027High impact
New oncology prior authorization code updates
Effective January 1, 2027, UnitedHealthcare is adding prior authorization requirements for 11 HCPCS oncology medication codes when administered in outpatient settings for cancer treatment. These codes include busulfan, leucovorin calcium, luspatercept, dexrazoxane, dinutuximab, octreotide, triptorelin, omidubicel, zoledronic acid, and cyclosporine. This change applies across commercial, Medicare Advantage, Medicaid, and Individual Exchange plans.
BCBS Oklahoma · Effective Jan 1, 2027High impact
New Digital Interfaces To Simplify Prior Authorization Requests
Effective January 1, 2027, this Blue Cross Blue Shield plan will launch new application programming interfaces (APIs) to streamline prior authorization requests and provide real-time access to patient data, encounter information, and claims data through your EHR system. This CMS-required update applies to Medicare Advantage, Medicaid, and select commercial members, reducing administrative burden and enabling faster treatment decisions.
BCBS Oklahoma · Effective Jan 1, 2027High impact
We’ll Begin Removing Recommended Clinical Review as an Optional Medical Necessity Review, Effective Jan. 1, 2027
Effective January 1, 2027, Blue Cross Blue Shield of Oklahoma will begin phasing out 'recommended clinical review' as an optional medical necessity review option for commercial members, with complete removal expected by end of 2027. Services that previously qualified for recommended clinical review may now require prior authorization instead. Medicare and Medicaid members are unaffected as they never had this option.
Ambetter · Effective Jan 1, 2027High impact
Ambetter of Oklahoma Billing Code Update for various HCPC H Codes: Effective 01/01/2027
Effective January 1, 2027, Ambetter of Oklahoma will discontinue coverage for 46 HCPCS H codes commonly used for behavioral health, substance abuse treatment, and related services. Simultaneously, H0006 coverage begins on the same date. The billing team must identify all affected claims and establish processes to deny or redirect these codes for Ambetter Oklahoma members.
BCBS Oklahoma · Effective Jan 1, 2027Medium impact
Changes Coming to the Medical Drug Benefit Program
Effective January 1, 2027, Blue Cross and Blue Shield of Oklahoma is expanding the Medical Drug Benefit Program to update coverage for specific prescription drugs administered by healthcare providers in clinical settings. The policy establishes new coverage rules for therapeutic alternatives, newly FDA-approved drugs, FDA-accelerated approval drugs, and drugs with limited medical benefit coverage. This change applies only to commercial members and requires providers to verify eligibility, check prior authorization requirements, and submit exception requests through the updated Medical Drug Benefit Program process.
BCBS Oklahoma · Effective Jan 1, 2027Medium impact
Updates to Behavioral Health Substance Abuse Criteria for Utilization Management
Effective January 1, 2027, Blue Cross Blue Shield of Oklahoma will expand use of ASAM (American Society of Addiction Medicine) Criteria 4.0 for medical necessity reviews of behavioral health and substance abuse services to include adolescents, in addition to the current use for adults. This changes the clinical criteria framework used for prior authorization decisions in these service categories.
BCBS Oklahoma · Effective Jan 1, 2027Medium impact
Watch for New Edge Benefit Plan Members in 2027
Beginning January 1, 2027, Blue Cross Blue Shield of Oklahoma will launch new Edge benefit plans powered by Easify℠. These are copay-only PPO plans with tiered copay options based on provider selection. Billing teams must verify member ID cards, confirm copay amounts via Availity Essentials before appointments, and ensure the rendering provider's NPI is included on all claims.
BCBS Oklahoma · Effective Feb 1, 2027Medium impact
Enhanced Review of Laboratory, Genetic and Molecular Testing Claims
Effective February 1, 2027, Blue Cross Blue Shield of Oklahoma will implement enhanced claims review for laboratory, genetic, and molecular testing services. Claims for dates of service on or after that date will be reviewed by Concert (a third-party utilization management company) against AMA and CMS National Correct Coding Initiative guidelines to ensure proper coding. Denied claims will receive notification with next steps.
Humana · Effective Oct 1, 2026High impact
Molecular Biomarkers for Prostate Cancer Risk Stratification - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for molecular biomarker tests used in prostate cancer risk stratification (effective 10/1/2026). The policy establishes coverage criteria for tests like ArteraAI, EpiSwitch, IsoPSA, MyProstateScore 2.0, ProMark, and ProsTAV, with coverage determinations based on MAC-specific LCDs/LCAs that vary by geographic jurisdiction. Billing teams must identify the correct MAC jurisdiction and apply the corresponding LCD requirements for each test ordered.
BCBS Oklahoma · Effective Oct 1, 2026High impact
Prior Authorization Changes for Some Commercial and Government Program Members
Blue Cross Blue Shield of Oklahoma is restructuring prior authorization requirements for some commercial and government program members, effective in phases starting October 1, 2026 through January 1, 2027. Changes include adding medical oncology drug and genetic testing codes to Carelon's review process, transferring miscellaneous codes to prior authorization, and modifications to Medicare Advantage oncology, orthotics, wound care, and DME code reviews. The policy also eliminates the 'Recommended Clinical Review' option for most commercial members by end of 2027.
Humana · Effective Oct 1, 2026High impact
Bariatric Surgery - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage bariatric surgery coverage policy (HUM-1020-005) effective October 1, 2026, that outlines coverage determinations, limitations, and coding requirements for various bariatric procedures. The policy applies Humana's Medicare Advantage coverage standards and references applicable MAC Local Coverage Determinations by geographic jurisdiction, with specific rules varying by state and MAC region.
BCBS Oklahoma · Effective Oct 1, 2026High impact
Prior Authorization Changes for Some Commercial and Government Program Members
Blue Cross Blue Shield of Oklahoma is restructuring prior authorization requirements for commercial and Medicare Advantage members effective October 1, 2026, and January 1, 2027. Behavioral health codes are being removed from BCBSOK review for commercial members, while new code categories (radiation oncology, miscellaneous codes, and emerging technology procedures) are being added to different utilization management vendors. Billing teams must verify eligibility and confirm which vendor handles prior authorization for each service, as requirements vary by plan type and effective date.
Ambetter · Effective Oct 1, 2026High impact
Ambetter Health Billing Code Update for CPT Codes 80320-80377: Effective 10/01/2026
Effective October 1, 2026, Ambetter Health will no longer reimburse CPT codes 80320-80377 (Definitive Drug Testing Procedures). Billing teams must transition to G-series bundled laboratory codes for all drug testing claims to avoid denials.
BCBS Oklahoma · Effective Oct 1, 2026High impact
Prior Authorization Changes for Some Commercial Members
Blue Cross Blue Shield of Oklahoma is restructuring prior authorization requirements for commercial members effective October 1, 2026. Musculoskeletal codes previously reviewed by Carelon and select outpatient service codes previously reviewed by BCBSOK will be removed from prior authorization requirements. Billing teams must verify current prior authorization requirements through Availity before rendering services, as the updated code lists will determine which services require authorization.
Humana · Effective Sep 16, 2026High impact
Applied Behavior Analysis - MEDICAID - OKLAHOMA (New)
Humana has released a new Applied Behavior Analysis (ABA) coverage policy for Oklahoma Medicaid effective 09/16/2026. The policy establishes coverage limits for ABA initial assessments (24 units/6 hours) and reassessments (16 units/4 hours every 6 months), with defined exception criteria for complex cases including regression, comorbid conditions, major treatment changes, severe behaviors, language barriers, and multi-system coordination. Billing teams must implement prior authorization requirements and ensure documentation supports medical necessity for any units exceeding standard limits.
Humana · Effective Sep 1, 2026High impact
Spinal Fusion Surgery - Medicare Advantage (Revised)
This is a revised Medicare Advantage medical coverage policy for spinal fusion surgery (effective 09/01/2026) that consolidates coverage determination, limitations, coding information, and evidence summaries for cervical, lumbar, and thoracic spinal fusion procedures. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) across geographic jurisdictions and outlines covered procedures including traditional fusion, minimally invasive approaches (DLIF, XLIF, MITLIF), sacroiliac joint fusion, and interlaminar fusion techniques. Billing teams must align claims submission with the applicable MAC LCD based on patient location and ensure procedures meet specific medical necessity criteria outlined in the referenced determinations.
Humana · Effective Sep 1, 2026High impact
Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for Benign Prostatic Hyperplasia treatments effective September 1, 2026. The policy outlines coverage determinations for multiple BPH treatment modalities including surgical procedures (TURP, prostatectomy, laser therapies), temporary implanted devices, stents, and diagnostic testing. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) that vary by geographic jurisdiction, requiring billing teams to verify applicable coverage rules based on patient location.
Humana · Effective Sep 1, 2026High impact
Ambulatory Cardiac Monitoring Devices - Medicare Advantage (Revised)
Humana Medicare Advantage has revised its Ambulatory Cardiac Monitoring Devices policy effective September 1, 2026. The policy provides updated coverage guidance for various cardiac monitoring technologies (Holter monitors, patch recorders, external loop monitors, implantable loop recorders, and mobile cardiac outpatient telemetry) with MAC-specific coverage determinations by geographic jurisdiction. The policy document appears incomplete but establishes that medical necessity determinations will follow applicable NCDs and LCDs based on the member's jurisdiction.
Oklahoma SoonerCare · Effective Sep 1, 2026High impact
Provider Letter 2026-14: Re: Applied Behavior Analysis Service Quality Reviews
OHCA is implementing a mandatory Service Quality Review (SQR) process for all Applied Behavior Analysis (ABA) providers effective September 2026. Non-compliance may result in penalties, billing retractions, or referrals to Program Integrity. The policy identifies 10 specific compliance concerns including uncertified staff, inadequate documentation, misaligned CPT billing, unsigned treatment plans, and billing-documentation mismatches.
Humana · Effective Aug 6, 2026High impact
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for neuroablative techniques used to treat chronic pain, effective 08/06/2026. The policy defines coverage criteria, eligible procedures (including radiofrequency ablation, cryoablation, chemical neurolysis, and specialized devices like Intracept), and references MAC-specific LCDs and billing codes by geographic jurisdiction. Billing teams must verify applicable MAC guidelines for their state and ensure claims comply with local coverage determinations.
Humana · Effective Aug 6, 2026High impact
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy on neuroablative techniques for chronic pain management, effective 08/06/2026. The policy defines covered denervation procedures (radiofrequency ablation, cryoablation, facet denervation, basivertebral nerve ablation, and others) and references MAC-specific LCDs and NCDs that vary by geographic jurisdiction. Billing teams must verify applicable MAC requirements for their region before processing claims for these procedures.
Humana · Effective Aug 3, 2026High impact
Genetic Testing for Hereditary Cancer - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy on genetic testing for hereditary cancer syndromes, effective August 3, 2026. The policy establishes coverage guidelines for germline genetic testing across multiple cancer types (melanoma, gastric cancer, neuroendocrine tumors, renal cell carcinoma, and others) and references specific MAC-based Local Coverage Determinations (LCDs) that vary by geographic jurisdiction. Billing teams must verify applicable MAC jurisdiction and LCD requirements before processing claims.
Humana · Effective Aug 3, 2026High impact
Breast Reconstruction - Medicare Advantage (Revised)
Humana Medicare Advantage has revised its breast reconstruction coverage policy (effective 08/03/2026) to clarify medical necessity criteria for reconstruction procedures following mastectomy, trauma, or congenital abnormalities. The policy applies MAC-specific Local Coverage Determinations (LCDs) by geographic jurisdiction and establishes criteria for determining coverage of implant removal, reduction mammaplasty, and related procedures. Billing teams must identify the appropriate MAC jurisdiction for each claim and apply the correct LCD requirements.
Humana · Effective Aug 3, 2026High impact
Breast Excision and Mastectomy - Medicare Advantage (Revised)
Humana Medicare Advantage has updated its Breast Excision and Mastectomy policy (HUM-1254-009) effective 08/03/2026. This revised policy clarifies coverage criteria for breast lesion excisions (CPT 19120, 19125), partial mastectomies (CPT 19301, 19302), and gynecomastia mastectomy (CPT 19300) across multiple MAC jurisdictions. The policy establishes specific medical necessity criteria based on biopsy results, lesion characteristics, and anatomical considerations, and applies jurisdiction-specific Local Coverage Determinations (LCDs) for Medicare Administrative Contractors.
Humana · Effective Aug 3, 2026High impact
Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy for Benign Prostatic Hyperplasia (BPH) treatments that became effective on August 3, 2026. The policy outlines coverage for multiple surgical and minimally invasive treatment modalities including TURP, laser therapies, temporary implanted devices, and stents, with specific coverage determinations varying by MAC jurisdiction. Billing teams must verify applicable MAC-specific LCDs and NCDs by geographic location before processing BPH treatment claims.
Oklahoma SoonerCare · Effective Aug 1, 2026High impact
Provider Letter 2026-12: Re: D1354 Reimbursement Rate Update
Oklahoma Health Care Authority (OHCA) is reducing reimbursement rates for dental code D1354 (interim caries arresting medicament application) effective August 1, 2026. Rates are decreasing from $76.22 to $18.29 for children and from $83.93 to $20.14 for adults—a 76% reduction. Billing teams must update fee schedules and claims processing systems immediately to avoid payment delays and claim denials.
BCBS Oklahoma · Effective Aug 1, 2026High impact
Prior Authorization Changes for Some Commercial Government Program Members
Blue Cross Blue Shield of Oklahoma is implementing prior authorization requirement changes for commercial and Medicare Advantage members, effective on staggered dates. Commercial members will see changes to radiology advanced imaging, molecular genetic lab testing, and medical oncology codes reviewed by Carelon, plus drug codes reviewed by BCBSOK starting October 1, 2026. Medicare Advantage members will experience Part B Step Therapy Program changes and miscellaneous code reviews starting August 1 and October 1, 2026.
Humana · Effective Jul 29, 2026High impact
Spinal Decompression Surgery - MEDICAID - OKLAHOMA (New)
Humana Oklahoma Medicaid establishes new coverage criteria for spinal decompression surgery (laminectomy, laminotomy, foraminectomy, foraminotomy) in cervical and lumbar spine. Policy requires specific clinical documentation, imaging correlation, and 6-week conservative treatment failure for most diagnoses, with exceptions for emergent conditions (fractures, infections, tumors, cauda equina syndrome). Billing teams must ensure prior authorization submissions include required medical necessity documentation.
Humana · Effective Jul 29, 2026High impact
Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (Revised)
Humana Oklahoma Medicaid updated its policy for chronic pain injections (epidural steroid injections, facet joint injections, sacroiliac joint injections, trigger point injections, and peripheral nerve blocks) effective July 29, 2026. The policy establishes specific coverage criteria including mandatory 4-week conservative treatment, radicular pain confirmation, imaging guidance requirements, and strict frequency/level limitations for procedures. Billing teams must ensure prior authorization compliance and proper documentation of conservative treatment attempts before claim submission.
BCBS Oklahoma · Effective Jul 28, 2026High impact
Reminder on MyBlue HMO℠ Referral Process for Specialty Care
This policy clarifies the MyBlue HMO referral process for specialty care services. Key points: specialty providers with valid PCP referrals can order additional services and obtain prior authorization without PCP approval; however, referrals to additional specialty providers require PCP notification; missing referrals result in claim denials. No referral is needed for direct PCP orders to in-network facilities for physical, occupational, or speech therapy.
BCBS Oklahoma · Effective Jul 8, 2026High impact
Two New Claims Editing Rules To Be Implemented in July 2026
Blue Cross Blue Shield of Oklahoma will implement two new claims editing rules on July 8, 2026 that will automatically deny claims with coding errors. The first rule checks for laterality modifier mismatches (LT/RT/50) with diagnoses, and the second validates HCPCS codes used with implant revenue codes 275, 276, and 278.
Humana · Effective Jul 1, 2026High impact
Humana Physician News: Q2 2026
This Q2 2026 Humana newsletter (published April 1, 2026, discovered November 1, 2026) contains multiple effective dates spanning past, ongoing, and future actions. Key changes include: (1) New prior authorization lists effective July 1, 2026, for Medicare Advantage, Dual Eligible SNPs, and Medicaid plans; (2) Medicaid provider-administered medication PAL changes for seven states; (3) PPO members inactive since May 1, 2024, were automatically unpaneled as of March 1, 2026; (4) New claims-based attribution rules for MA products effective April 1, 2026; and (5) Published claims payment policies including a new Paper Claim Administrative Fee. The newsletter emphasizes timely prior authorization submission before services are fully furnished to avoid claim denial and retroactive authorization processing.
BCBS Oklahoma · Effective Jul 1, 2026High impact
Register for Webinar on Coding for Evaluation and Management Claims
Effective July 1, 2026, Blue Cross Blue Shield of Oklahoma refined their claims editing and review process for office, inpatient, and outpatient evaluation and management (E/M) services for commercial members. Three mandatory webinars are being offered in October 2026 to train providers on these coding and claims submission changes. Providers must review the updated Reimbursement Policy 024 (RP024) to understand the new E/M coding requirements.
Oklahoma SoonerCare · Effective Jul 1, 2026High impact
Provider Letter 2026-17: Rates Calculation Correction and Claims Recycling
OHCA identified and corrected a fee schedule calculation error that was implemented July 1, 2026. The Oklahoma Health Care Authority is retroactively adjusting all impacted Title XIX (Medicaid) fee-for-service claims over multiple weeks, with adjustments visible on weekly remittance advice starting September 30, 2026. This correction aligns rates with current CMS fee schedules and is not a methodology change.
BCBS Oklahoma · Effective Jul 1, 2026High impact
Claim Editing Changes for Evaluation and Management Services for Many Commercial Members, Effective July 1, 2026
Effective July 1, 2026, Blue Cross Blue Shield of Oklahoma will implement enhanced claims editing for E&M services on commercial plans, automatically reducing reimbursement to validated service levels when billed services don't support the level claimed. Providers can submit medical records if they disagree with the reimbursement adjustment.
Oklahoma SoonerCare · Effective Jun 4, 2026High impact
Provider Letter 2026-11: Re: Immediate Medicaid Coverage Change; Senate Bill 904 (2026)
Oklahoma Medicaid immediately prohibits coverage of surgical procedures and pharmaceuticals for gender transition under Senate Bill 904. Claims with gender dysphoria diagnoses will suspend for review, and prior authorization is now required for specific hormone therapies.
BCBS Oklahoma · Effective Jun 1, 2026High impact
Alacura for Medical Transportation Management: Learn More
Effective June 1, 2026, Alacura Medical Transportation Management began medical necessity review of air and ground medical transportation for some members with Blue Cross and Blue Shield of Oklahoma (BCBSOK). The review includes prior authorization, recommended clinical review and retrospective claim review for fully insured and retail PPO, POS and HMO members. This change is already in effect, and the program does not apply to Blue Cross and Blue Shield Federal Employee Program, Medicare, Medicaid or self-funded benefit plans.
Humana · Effective May 13, 2026High impact
Anticholinergic Polypharmacy Agents (Revised)
Humana has updated its Anticholinergic Polypharmacy guidance (revised May 13, 2026) to implement a safety edit that restricts concurrent use of multiple anticholinergic medications for members aged 65+, unless the provider attests that benefits outweigh risks per American Geriatrics Society Beers Criteria and provides patient education. Members in hospice are exempt from this restriction. This affects pharmacy claims across Medicare and multiple state Medicaid programs.
Humana · Effective Apr 15, 2026High impact
Pediatric Antipsychotic Utilization Program (Revised)
Humana has revised its Pediatric Antipsychotic Utilization Program (effective April 15, 2026) establishing stricter prior authorization requirements for all antipsychotic medications in pediatric patients aged <6 years (requires compendia-supported diagnosis) and ≥6 years (standard coverage), plus new restrictions on concurrent antipsychotic use in patients ≥6 years. This policy applies to Florida, South Carolina, Oklahoma, and Virginia Medicaid plans and affects 60+ antipsychotic formulations across typical and atypical classes.
BCBS Oklahoma · Effective Apr 1, 2026High impact
Prior Authorization Changes for Some Commercial and Government Program Members
BCBS Oklahoma is implementing major prior authorization changes across multiple phases starting April 1, 2026, with most changes effective July 1, 2026. The changes affect oncology, radiology, advanced imaging, molecular genetics, pharmacy, and orthotic services, with different utilization management vendors (Carelon, EviCore, BCBSOK) reviewing different service categories.
UnitedHealthcare · Effective Apr 1, 2026High impact
New DME process for select members in multiple states
Beginning April 1, 2026, Synapse Health will manage durable medical equipment (DME) ordering and fulfillment for UnitedHealthcare Medicare Advantage plans in multiple states. DME prescribers must use Synapse Health's e-prescribing portal, and DME providers must join the Synapse Health network to continue serving these members.
BCBS Oklahoma · Effective Mar 5, 2026High impact
Providers with Unused Record IDs May Be Terminated from Networks
Blue Cross Blue Shield of Oklahoma will terminate providers from networks if they don't file claims using their billing/rendering NPI and TIN within 24 months. Providers must actively use their record IDs by filing claims regularly or risk automatic network termination.
Humana · Effective Jan 7, 2026High impact
Spine Surgery - MEDICAID - OKLAHOMA (New)
New Medicaid spine surgery policy for Oklahoma establishes coverage criteria for artificial disc replacement, minimally invasive sacroiliac joint fusion, spinal fusion, and vertebral body tethering procedures. The policy details specific requirements including age limits, conservative treatment failures, and contraindications that must be met for coverage approval.
Humana · Effective Jan 7, 2026High impact
Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (New)
New Medicaid policy for Oklahoma establishes coverage criteria for chronic pain injections including epidural steroid injections, sacroiliac joint injections, and trigger point injections. The policy requires 4 weeks of conservative treatment failure and limits injection frequency and number of nerve root levels per session.
Oklahoma SoonerCare · Effective Jan 1, 2026High impact
Provider Letter 2026-04: RE: D9248 update
Oklahoma Medicaid terminated dental code D9248 and replaced it with four new codes (D9244, D9245, D9246, D9247). Due to lower reimbursement rates for D9244 and D9245, Oklahoma will update these rates to match the previous D9248 rate of $135.67 by April 1, 2026.
BCBS Oklahoma · Effective Jan 1, 2026High impact
Update: Prior Authorization Changes for Medicare Advantage Members, Effective Jan. 1, 2026
Effective January 1, 2026, prior authorization requests for Medicare Advantage members must now be submitted directly to BCBSOK instead of EviCore healthcare for five specific care categories: advanced imaging, musculoskeletal services, sleep medicine, medical specialty drugs, and genetic testing. This represents a significant workflow change requiring immediate updates to authorization submission processes.
BCBS Oklahoma · Effective Jan 1, 2026High impact
Changes to Our Prior Authorization Programs for Medicare Advantage
Effective January 1, 2026, BCBS Oklahoma has transitioned prior authorization management for Medicare Advantage members from EviCore to internal BCBS Oklahoma management for most care categories, reducing prior authorization requirements to fewer than 20% of codes. Proton Beam Therapy Services will continue to be managed by EviCore.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

New Claims Editing Rules To Be Implemented in December 2026

Prior Authorization Changes for Some Government Program Members

Blue Cross Medicare Advantage (HMO)℠ Members Transitioning to HealthSpring℠ Plan for 2027

New oncology prior authorization code updates

New Digital Interfaces To Simplify Prior Authorization Requests

We’ll Begin Removing Recommended Clinical Review as an Optional Medical Necessity Review, Effective Jan. 1, 2027

Ambetter of Oklahoma Billing Code Update for various HCPC H Codes: Effective 01/01/2027

Changes Coming to the Medical Drug Benefit Program

Updates to Behavioral Health Substance Abuse Criteria for Utilization Management

Watch for New Edge Benefit Plan Members in 2027

Enhanced Review of Laboratory, Genetic and Molecular Testing Claims

Molecular Biomarkers for Prostate Cancer Risk Stratification - Medicare Advantage (Revised)

Prior Authorization Changes for Some Commercial and Government Program Members

Bariatric Surgery - Medicare Advantage (Revised)

Prior Authorization Changes for Some Commercial and Government Program Members

Ambetter Health Billing Code Update for CPT Codes 80320-80377: Effective 10/01/2026

Prior Authorization Changes for Some Commercial Members

Applied Behavior Analysis - MEDICAID - OKLAHOMA (New)

Spinal Fusion Surgery - Medicare Advantage (Revised)

Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)

Ambulatory Cardiac Monitoring Devices - Medicare Advantage (Revised)

Provider Letter 2026-14: Re: Applied Behavior Analysis Service Quality Reviews

Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)

Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)

Genetic Testing for Hereditary Cancer - Medicare Advantage (Revised)

Breast Reconstruction - Medicare Advantage (Revised)

Breast Excision and Mastectomy - Medicare Advantage (Revised)

Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)

Provider Letter 2026-12: Re: D1354 Reimbursement Rate Update

Prior Authorization Changes for Some Commercial Government Program Members

Spinal Decompression Surgery - MEDICAID - OKLAHOMA (New)

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (Revised)

Reminder on MyBlue HMO℠ Referral Process for Specialty Care

Two New Claims Editing Rules To Be Implemented in July 2026

Humana Physician News: Q2 2026

Register for Webinar on Coding for Evaluation and Management Claims

Provider Letter 2026-17: Rates Calculation Correction and Claims Recycling

Claim Editing Changes for Evaluation and Management Services for Many Commercial Members, Effective July 1, 2026

Provider Letter 2026-11: Re: Immediate Medicaid Coverage Change; Senate Bill 904 (2026)

Alacura for Medical Transportation Management: Learn More

Anticholinergic Polypharmacy Agents (Revised)

Pediatric Antipsychotic Utilization Program (Revised)

Prior Authorization Changes for Some Commercial and Government Program Members

New DME process for select members in multiple states

Providers with Unused Record IDs May Be Terminated from Networks

Spine Surgery - MEDICAID - OKLAHOMA (New)

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (New)

Provider Letter 2026-04: RE: D9248 update

Update: Prior Authorization Changes for Medicare Advantage Members, Effective Jan. 1, 2026

Changes to Our Prior Authorization Programs for Medicare Advantage

Prior Authorization Changes for Some Commercial Members

Prior Authorization Changes for Some Commercial Government Program Members